09/14/2024 | Press release | Distributed by Public on 09/15/2024 22:48

iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow up Interim Analysis of GALAXIES Lung 201 Study of Belrestotug + Dostarlimab in[...]

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Back

 Download the original document